Conflict of Interest
Jennifer Doudna Disclosures
The Regents of the University of California have patents issued and pending for CRISPR technologies on which J.A.D. is an inventor.
J.A.D. is a cofounder of Caribou Biosciences, Editas Medicine, Scribe Therapeutics, and Mammoth Biosciences. J.A.D. is a scientific advisory board member of Caribou Biosciences, Intellia Therapeutics, eFFECTOR Therapeutics, Scribe Therapeutics, Mammoth Biosciences, Synthego, Metagenomi and Inari. J.A.D. is a Director at Johnson & Johnson and has research projects sponsored by Biogen , Pfizer, Apple Tree Partners and Roche.